Product catalog antigen listed by alphabetic starting with M
| Items 1 to 100 of 1.285 total | 13 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| 10-288-22405F | M-phase phosphoprotein 6 variant antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22405F-50 | M-phase phosphoprotein 6 variant antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00004074-Q01-10 | M6PR antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004074-Q01-25 | M6PR antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010226-P01-10 | M6PRBP1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010226-P01-25 | M6PRBP1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004081-P01-02 | MAB21L1 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004081-P01-10 | MAB21L1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004081-P01-25 | MAB21L1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004081-Q01-10 | MAB21L1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004081-Q01-25 | MAB21L1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010586-P01-10 | MAB21L2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010586-P01-25 | MAB21L2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023499-Q01-10 | MACF1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023499-Q01-25 | MACF1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22527F | Macrophage capping protein antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22527F-50 | Macrophage capping protein antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| PA099 | Macrophage Chemotactic Protein-2 (MCP-2) antigen | ||||||
| Human | >99% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA099X | Macrophage Chemotactic Protein-2 (MCP-2) antigen | ||||||
| Human | >99% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA193 | Macrophage Chemotactic Protein-2 (MCP-2) antigen | ||||||
| Mouse | Purified | >99% | E. coli | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA193X | Macrophage Chemotactic Protein-2 (MCP-2) antigen | ||||||
| Mouse | Purified | >99% | E. coli | 20 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| PA024 | Macrophage Chemotactic Protein-3 (MCP-3) antigen | ||||||
| Mouse | >99% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA024X | Macrophage Chemotactic Protein-3 (MCP-3) antigen | ||||||
| Mouse | >99% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA100 | Macrophage Chemotactic Protein-3 (MCP-3) antigen | ||||||
| Human | >99% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA100X | Macrophage Chemotactic Protein-3 (MCP-3) antigen | ||||||
| Human | >99% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA101 | Macrophage Chemotactic Protein-4 (MCP-4) (NCC-1) antigen | ||||||
| Human | >95% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA101X | Macrophage Chemotactic Protein-4 (MCP-4) (NCC-1) antigen | ||||||
| Human | >95% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA025 | Macrophage Chemotactic Protein-5 (MCP-5) antigen | ||||||
| Mouse | >99% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA025X | Macrophage Chemotactic Protein-5 (MCP-5) antigen | ||||||
| Mouse | >99% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA102 | Macrophage Colony Stimulating Factor (M-CSF) antigen | ||||||
| Human | >98% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA102X | Macrophage Colony Stimulating Factor (M-CSF) antigen | ||||||
| Human | >98% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA268 | Macrophage Colony Stimulating Factor (M-CSF) antigen | ||||||
| Mouse | >98% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA268X | Macrophage Colony Stimulating Factor (M-CSF) antigen | ||||||
| Mouse | >98% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| GTX29674 | Macrophage Inflammatory Protein 1 alpha protein antigen | ||||||
| 20 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX29782 | Macrophage Inflammatory Protein 1 alpha protein antigen | ||||||
| Purified | 20 µg / --- | ||||||
| GeneTex Inc. | |||||||
| GTX29928 | Macrophage Inflammatory Protein 1 alpha protein antigen | ||||||
| 10 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX29676 | Macrophage Inflammatory Protein 1 beta protein antigen | ||||||
| 10 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX29832 | Macrophage Inflammatory Protein 3 beta protein antigen | ||||||
| Purified | 20 µg / --- | ||||||
| GeneTex Inc. | |||||||
| PA026 | Macrophage Inflammatory Protein-1 alpha (MIP-1a) antigen | ||||||
| Mouse | >99% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA026X | Macrophage Inflammatory Protein-1 alpha (MIP-1a) antigen | ||||||
| Mouse | >99% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA043 | Macrophage Inflammatory Protein-1 alpha (MIP-1a) antigen | ||||||
| Rat | >95% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA043X | Macrophage Inflammatory Protein-1 alpha (MIP-1a) antigen | ||||||
| Rat | >95% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA106 | Macrophage Inflammatory Protein-1 alpha (MIP-1a) antigen | ||||||
| Human | >99% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA106X | Macrophage Inflammatory Protein-1 alpha (MIP-1a) antigen | ||||||
| Human | >99% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| 50158P-1000 | Macrophage Inflammatory Protein-1 alpha (MIP-1a) antigen | ||||||
| Human | >98% | E. coli | 1 mg / --- | ||||
| QED Bioscience Inc. | |||||||
| 50158P-20 | Macrophage Inflammatory Protein-1 alpha (MIP-1a) antigen | ||||||
| Human | >98% | E. coli | 20 µg / --- | ||||
| QED Bioscience Inc. | |||||||
| 50158P-5 | Macrophage Inflammatory Protein-1 alpha (MIP-1a) antigen | ||||||
| Human | >98% | E. coli | 5 µg / --- | ||||
| QED Bioscience Inc. | |||||||
| PA107 | Macrophage Inflammatory Protein-1 beta (MIP-1b) antigen | ||||||
| Human | >99% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA107X | Macrophage Inflammatory Protein-1 beta (MIP-1b) antigen | ||||||
| Human | >99% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA250 | Macrophage Inflammatory Protein-1 beta (MIP-1b) antigen | ||||||
| Mouse | >99% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA250X | Macrophage Inflammatory Protein-1 beta (MIP-1b) antigen | ||||||
| Mouse | >99% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA251 | Macrophage Inflammatory Protein-1 beta (MIP-1b) antigen | ||||||
| Rat | >99% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA251X | Macrophage Inflammatory Protein-1 beta (MIP-1b) antigen | ||||||
| Rat | >99% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA027 | Macrophage Inflammatory Protein-1 gamma (MIP-1g) antigen | ||||||
| Mouse | >99% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA027X | Macrophage Inflammatory Protein-1 gamma (MIP-1g) antigen | ||||||
| Mouse | >99% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA028 | Macrophage Inflammatory Protein-2 (MIP-2 beta) (Gro beta, CXCL2) antigen | ||||||
| Mouse | >98% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA028X | Macrophage Inflammatory Protein-2 (MIP-2 beta) (Gro beta, CXCL2) antigen | ||||||
| Mouse | >98% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA038 | Macrophage Inflammatory Protein-2 (MIP-2 beta) (Gro beta, CXCL2) antigen | ||||||
| Rat | >98% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA038X | Macrophage Inflammatory Protein-2 (MIP-2 beta) (Gro beta, CXCL2) antigen | ||||||
| Rat | >98% | E. coli | 25 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA063 | Macrophage Inflammatory Protein-2 (MIP-2 beta) (Gro beta, CXCL2) antigen | ||||||
| Human | >98% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA063X | Macrophage Inflammatory Protein-2 (MIP-2 beta) (Gro beta, CXCL2) antigen | ||||||
| Human | >98% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA157 | Macrophage Inflammatory Protein-2 (MIP-2 beta) (Gro beta, CXCL2) antigen | ||||||
| viral | >98% | E. coli | 10 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA157X | Macrophage Inflammatory Protein-2 (MIP-2 beta) (Gro beta, CXCL2) antigen | ||||||
| viral | >98% | E. coli | 50 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA108 | Macrophage Inflammatory Protein-3 (MIP-3) (MPIF-1) antigen | ||||||
| Human | >99% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA108X | Macrophage Inflammatory Protein-3 (MIP-3) (MPIF-1) antigen | ||||||
| Human | >99% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA109 | Macrophage Inflammatory Protein-3 alpha (MIP-3 alpha ) (Exodus, LARC) antigen | ||||||
| Human | >99% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA109X | Macrophage Inflammatory Protein-3 alpha (MIP-3 alpha ) (Exodus, LARC) antigen | ||||||
| Human | >99% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA254 | Macrophage Inflammatory Protein-3 alpha (MIP-3 alpha ) (Exodus, LARC) antigen | ||||||
| Mouse | >99% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA254X | Macrophage Inflammatory Protein-3 alpha (MIP-3 alpha ) (Exodus, LARC) antigen | ||||||
| Mouse | >99% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA110 | Macrophage Inflammatory Protein-3 beta (MIP-3 beta) (Exodus-3, ELC) antigen | ||||||
| Human | >99% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA110X | Macrophage Inflammatory Protein-3 beta (MIP-3 beta) (Exodus-3, ELC) antigen | ||||||
| Human | >99% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA255 | Macrophage Inflammatory Protein-3 beta (MIP-3 beta) (Exodus-3, ELC) antigen | ||||||
| Mouse | >99% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA255X | Macrophage Inflammatory Protein-3 beta (MIP-3 beta) (Exodus-3, ELC) antigen | ||||||
| Mouse | >99% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA111 | Macrophage Inflammatory Protein-4 (MIP-4) (PARC) antigen | ||||||
| Human | >98% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA111X | Macrophage Inflammatory Protein-4 (MIP-4) (PARC) antigen | ||||||
| Human | >98% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| SA6053 | Macrophage Inhibitory Factor (MIF, 1-114 His-tagged) antigen | ||||||
| Human | Purified | >95% | E. coli | 0.1 mg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| SA6053X | Macrophage Inhibitory Factor (MIF, 1-114 His-tagged) antigen | ||||||
| Human | Purified | >95% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| AR03003PU-N | Macrophage Migration Inhibitory Factor (MIF) (1-115) antigen | ||||||
| Human | Purified | >98% | E. coli | 0.5 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| AR03003PU-S | Macrophage Migration Inhibitory Factor (MIF) (1-115) antigen | ||||||
| Human | Purified | >98% | E. coli | 0.1 mg / US$ 455 | |||
| Acris Antibodies GmbH | |||||||
| H00008379-Q01-10 | MAD1L1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008379-Q01-25 | MAD1L1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004085-P01-10 | MAD2L1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004085-P01-25 | MAD2L1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22372F | MAD2L1-binding protein antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22372F-50 | MAD2L1-binding protein antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00010459-P01-10 | MAD2L2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010459-P01-25 | MAD2L2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| GTX11254 | Mad2L2 peptide (3-14) antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX28384 | MADD peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| H00010296-P01-10 | MAEA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010296-P01-25 | MAEA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004094-Q01-10 | MAF antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004094-Q01-25 | MAF antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00389692-Q01-10 | MAFA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00389692-Q01-25 | MAFA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004099-Q01-10 | MAG antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004099-Q01-25 | MAG antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA1363 | MAGE-1 antigen | ||||||
| Human | Purified | - | E. coli | 2 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| PA1363X | MAGE-1 antigen | ||||||
| Human | Purified | - | E. coli | 5 µg / US$ 495 | |||
| Acris Antibodies GmbH | |||||||
| PA1363XC | MAGE-1 antigen | ||||||
| Human | Purified | - | E. coli | 10 µg / ask | |||
| Acris Antibodies GmbH | |||||||
| Items 1 to 100 of 1.285 total | 13 Page(s): |


